Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Prepaid Assets: 2021-2024

Historic Prepaid Assets for LifeStance Health (LFST) over the last 4 years, with FY2024 value amounting to $26.1 million.

  • LifeStance Health's Prepaid Assets rose 3489.18% to $35.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.4 million, marking a year-over-year increase of 3489.18%. This contributed to the annual value of $26.1 million for FY2024, which is 2155.61% up from last year.
  • According to the latest figures from FY2024, LifeStance Health's Prepaid Assets is $26.1 million, which was up 2155.61% from $21.5 million recorded in FY2023.
  • Over the past 5 years, LifeStance Health's Prepaid Assets peaked at $42.4 million during FY2021, and registered a low of $21.5 million during FY2023.
  • Moreover, its 4-year median value for Prepaid Assets was $24.9 million (2022), whereas its average is $28.4 million.
  • As far as peak fluctuations go, LifeStance Health's Prepaid Assets crashed by 4404.07% in 2022, and later surged by 2155.61% in 2024.
  • Over the past 4 years, LifeStance Health's Prepaid Assets (Annual) stood at $42.4 million in 2021, then plummeted by 44.04% to $23.7 million in 2022, then fell by 9.4% to $21.5 million in 2023, then grew by 21.56% to $26.1 million in 2024.
  • Its Prepaid Assets stands at $26.1 million for FY2024, versus $21.5 million for FY2023 and $23.7 million for FY2022.